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Available online 2 March 2018Large studies investigating the psychosocial effects of lifestyle interventions in patients with a severe mental ill-
ness (SMI) are scarce, especially in residential patients. This large, randomized controlled, multicentre pragmatic
trial assessed the psychosocial effects of a combined diet-and-exercise lifestyle intervention targeting the
obesogenic environment of SMI residential patients. Twenty-nine sheltered and clinical care teams were ran-
domized into intervention (n = 15) or control (n = 14) arm. Team tailored diet-and-exercise lifestyle plans
were set up to change the obesogenic environment into a healthier setting, and team members were trained
in supporting patients to make healthier choices. The control group received care-as-usual. The Calgary Depres-
sion Scale for Schizophrenia (CDSS), Positive and Negative Syndrome Scale (PANSS), Health of the Nation Out-
come Scales (HoNOS) and the Manchester Short Assessment of Quality of Life (MANSA) were assessed at
baseline and after three and twelve months. Data were available for 384 intervention and 386 control patients
(48.6 ± 12.5 years old, 62.7% males, 73.7% psychotic disorder). Linear mixed model analysis showed no psycho-
social improvements in the intervention group compared to care-as-usual; the intervention group showed a
slightly reduced quality of life (overall) and a small increase in depressive symptoms (clinical care facilities)
and psychotic symptoms (sheltered facilities). Thismay be due to difficulties with implementation, the interven-
tion not being specifically designed for improvements inmentalwell-being, or the small change approach, which
may take longer to reach an effect. Further research might elucidate what type of lifestyle intervention under
what circumstances positively affects psychosocial outcomes in this population.







Increased awareness of the somatic health of patients with a severe
mental illness (SMI) has resulted in a large body of research on lifestyle
interventions aiming atweight loss, weight gain prevention or improve-
ments in cardiometabolic health. Lifestyle interventions can improve
cardiometabolic risk factors such as waist circumference, triglycerides
and fasting glucose in psychotic patients (Bruins et al., 2014). Lifestyleer Groningen, Department of
, The Netherlands.changes may also affect psychosocial well-being because of the associa-
tion of lifestyle factors with symptoms of depression and anxiety in the
general population (Lang et al., 2015; Penedo and Dahn, 2005; Ross and
Hayes, 1988), and with negative and depressive symptoms in schizo-
phrenia (Rosenbaum et al., 2014; Vancampfort et al., 2012).
A number of studies have investigated the effect of lifestyle interven-
tions on psychosocial functioning in SMI patients. For example, pro-
grams of physical exercise have shown to reduce psychotic symptoms
(Beebe et al., 2005; Rimes et al., 2015; Scheewe et al., 2013), depressive
symptoms (Acil et al., 2008; Scheewe et al., 2013), anxiety (Wipfli et al.,
2008) and stress (Hoffmann et al., 2005) and improved quality of life
was found after a nutritional intervention (Evans et al., 2005) and a psy-
cho-educational weight control program (Mauri et al., 2008). However,
408 A.P.M. Stiekema et al. / Schizophrenia Research 199 (2018) 407–413symptomatic stability or unchanged quality of life were also reported
(Ball et al., 2001; Brar et al., 2005; Forsberg et al., 2010; Heggelund et
al., 2011; Kwon et al., 2006; Poulin et al., 2007; Wärdig et al., 2016).
Drawing firm conclusions about the effect of lifestyle interventions on
mental health is complicated due to small sample sizes (Acil et al.,
2008; Ball et al., 2001; Beebe et al., 2005; Evans et al., 2004; Forsberg
et al., 2010; Heggelund et al., 2011; Kwon et al., 2006; Mauri et al.,
2008) or the lack of a control group (Daumit et al., 2011; Hoffmann et
al., 2005; Richardson et al., 2005). Moreover, large trials including resi-
dential patients are lacking.
Adopting a healthy lifestyle is especially challenging for residential
patients, due to the obesogenic environment of residential facilities.
An obesogenic environment is characterized by limited opportunities
for exercising and easy access to high-calorie food as opposed to healthy
alternatives (Swinburn et al., 1999). Small environmental changes have
led to weight loss in an uncontrolled inpatient population (Cohn et al.,
2010). The Effectiveness of Lifestyle Interventions in PSychiatry
(ELIPS) study was designed to change the obesogenic environment of
residential facilities, with the primary aim to improve patients' somatic
health (Looijmans et al., 2014). The intervention successfully reduced
waist circumference and metabolic syndrome Z-score after three
months intervention (Looijmans et al., 2017). The current paper de-
scribes the secondary, psychosocial, outcomes of the ELIPS study. We
hypothesized that the lifestyle intervention would lead to reduced de-
pressive and psychotic symptoms and improved overall functioning
and quality of life.Fig. 1. Flowchart of patients in the ELIPS trial. A total of 770 patients have at least one psychos
retraceable in flow).2. Materials and methods
2.1. Design
The study protocol of thismulticentre cluster randomized controlled
pragmatic trial was published elsewhere (Looijmans et al., 2014) and
will be shortly explained below. The Medical Ethical Committee for Re-
search in Mental Health Care (Metigg) concluded that study protocol
and use of anonymized data from Routine Outcome Monitoring
(ROM; below) was in accordance with the Declaration of Helsinki and
(inter)national regulations, and that the study did not fall under the
scope of the Medical Research Involving Human Subjects Act, thereby
waiving informed consent. The trial was registered in the Dutch Trial
Registry (NTR2720, www.trialregister.nl).
2.2. Study population
Out of eighteen sheltered and 11 long-term clinical care teams of
two psychiatric institutions (Lentis and GGZ Friesland) in the Nether-
lands, clusters were made for teams that were comparable in terms of
institution, location (rural or city), living situation (sheltered or clini-
cal), and caseload (ranging from 20 to 65). Within each cluster, teams
were randomly assigned to the lifestyle intervention or the treatment
as usual control group, by a computerized random number generator
by a non-participating research nurse. Recruitment was from Septem-
ber 2010 till December 2011. Patients taking part in the annual ROMocial measure at baseline or 12-months follow-up and were included in the analysis (not
409A.P.M. Stiekema et al. / Schizophrenia Research 199 (2018) 407–413screening (addressed below) were automatically included. Exclusion
criteria were age below 18, pregnancy, diagnosis of Korsakov's syn-
drome or inability to perform physical activitymeasurements. The sam-
ple size calculation was based on the primary outcome (waist
circumference) and showed that 240 patients were needed in both
the control and intervention group (Looijmans et al., 2014).2.3. Intervention
Teams of health care professionals were trained to adjust the
obesogenic environment according to pre-determined ELIPS lifestyle
goals: 1) At least two physical activities per week (e.g. counselling con-
versations during a walk outside rather than sitting in the office, pa-
tients walk/cycle to shop for own groceries, organise group walks one
or twice a week, organise a weekly football activity, WII-sports activity,
or fitness centre visit), 2) At least three changes in daily food supply that
favor health (e.g. offer low-fat cheese and whole wheat alternatives to
white bread, pasta and rice, reduce consumption of sweetened dairy
product or cakes, buy fresh vegetables rather than canned vegetables,
offer snacks in small portions, and/or only in theweekends), 3) Aweek-
ly food focused activity (e.g. a workshop on buying, cooking and eating
healthy foods, create a daily fruit moment, make a shopping list togeth-
er, buy healthy groceries together, cook a healthy meal together or
make smoothies together) and 4) A sustainable change on organization
level (e.g. reduce access to food cupboards, adjust food supply in can-
teen (selling fried snacks only twice per week), provide a gym, set up
contracts with fitness centres, purchase a WII sports, prepare breakfast
every morning or put nutrition and physical activity standard on the
team meeting's agenda) (Looijmans et al., 2014). We aimed for small
changes because this has a high chance to lead to changes that are sus-
tainable in long-term (Treweek and Zwarenstein, 2009). Consulting
both patients and staff on their preferences (see Supplementary
methods for more detailed information on patient involvement), twoTable 1
Baseline characteristics of study participants.a
Variable Nb Total
Demographical
Age, yrs 770 48.0 ± 12.5
Male sex 770 63.2
Housing 770
Sheltered living 59.0






Substance related disorder 12.5
Developmental disorder 9.2
Psychiatric comorbidity 24.8
BMI, kg/m2 613 28.1 ± 6.3
Overweight (25–30 kg/m2) 613 34.1
Obese (N30 kg/m2) 613 32.0
Antipsychotic medication
Antipsychotics 651 90.0
Chlorpromazine equivalentc 635 400 [153; 600]
Scores for dependent variables
CDSSd 406 1.0 [0.0; 4.0]
PANSS 481 17.5 ± 6.2
HoNOS 562 13.4 ± 6.2
MANSA 578 60.1 ± 12.4
Abbreviations: BMI: Body Mass Index; CDSS: Calgary Depression Scale for Schizophrenia; PANS
Outcome Scales; MANSA: Manchester Short Assessment of Quality of Life.
p-values significant at alpha b 0.5 were indicated in bold.
a Table represents mean ± standard deviation, median [25th;75th percentile] or percentage
b The total N differs per variable due to missing data.
c Chlorpromazine equivalents of antipsychotic dosage were calculated according to Gardner
d Median was presented because of the non-normal distribution of scores.lifestyle coaches per team set up a lifestyle plan based on the ELIPS
goals and team specific (un)healthy behaviors, activities, opportunities
and logistic possibilities (1-month preparation phase). The lifestyle
coaches worked out these plans by organizing activities and workshops
to increase patients' intrinsic motivation and by training the teams in
creating a healthy environment and stimulating a healthier lifestyle
(3-month implementation phase). Teams gradually took over the re-
sponsibility and set goals to achieve in the next period (9-month mon-
itoring phase). We hypothesized that improvements could be achieved
in the implementation phase and sustained during and after the moni-
toring phase.2.4. Assessments
Outcomes were administered by trained nurses during ROM, a stan-
dard care annual screening of mental and physical health. ROM proce-
dures were fully explained to participants, after which they were free
to opt-out for the use of anonymized data for research purposes.
ROM-nurseswere blind for the patients' allocation (except for one loca-
tion where two teams assessed each other's patients). Regular assess-
ments were used for the baseline and 12-month measurements with
an additional ROM-screening for the 3-month measurement, for
which participants received a €5,00 fee. Age, gender, living situation
and medication were abstracted from patient charts.
The 9-item Calgary Depression Scale for Schizophrenia (CDSS;
Addington et al., 1990) was used to assess depressive symptoms. Scores
range from zero (absent) to three (severe) and were assessed during a
structured interview and summed. The CDSS has good psychometric
properties (Addington et al., 1996).
Psychotic symptomswere assessed using a shortened version of the
Positive and Negative Syndrome Scale based on remission criteria
(PANSS; Andreasen et al., 2005; Kay et al., 1987). Scores on the items
assessing delusions, conceptual disorganization, hallucinatory behavior,Intervention group Control group p-Values















450 [205; 640] 300 [150; 600] .006
1.0 [0.0; 3.8] 2.0 [0.0; 5.0] .003
17.7 ± 6.2 17.3 ± 6.1 .560
13.2 ± 6.0 13.6 ± 6.4 .429
61.5 ± 12.0 58.9 ± 12.7 .011
S: Positive and Negative Syndrome Scale – remission items; HoNOS: Health of the Nation
.
et al. (2010).
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posturing and unusual thought content range from one (absent) to
seven (extreme) and were summed.
Overall functioningwasmeasured with the clinician-rated Health of
the Nation Outcome Scales (HoNOS; Wing et al., 1998). Twelve ques-
tions on four domains (behavioral problems, organic problems, psycho-
logical symptoms, social problems) range from zero (no problems) to
four (severe problems) and were summed. The scale has moderately
high internal consistency and interrater reliability (Wing et al., 1998).
Quality of life wasmeasured with theManchester Short Assessment
of Quality of Life (MANSA; Priebe et al., 1999), a 12-item self-report
questionnaire capturing satisfaction within several psychosocial do-
mains, scored on a scale from one (could not be worse) to seven
(could not be better). Scores were summed. The MANSA has good con-
struct validity and internal consistency (Priebe et al., 1999).
2.5. Statistical analysis
Non-normally distributed data were transformed. Group differences
on baseline characteristics were examined with the chi-square test for
categorical variables, independent Student's t-tests for normally distrib-
uted continuous variables and Mann-Whitney U tests for non-normallyTable 2
Psychosocial outcomes after three and twelve months of lifestyle intervention in SMI residenti
β




Intervention ∗ three monthsc 0.19
Intervention ∗ twelve monthsd 0.17




Intervention ∗ three monthsc 0.17
Intervention ∗ twelve monthsd 0.77




Intervention ∗ three monthsc −0.02
Intervention ∗ twelve monthsd 0.02




Intervention ∗ three monthsc −2.80
Intervention ∗ twelve monthsd −4.18
Note: in order to calculate the estimated mean differences between the intervention and contr
group, 1 for the intervention group:
Y3 months ¼ βIntervention  X1 þ βThree months þ βInterventionThree months  X2
Y12 months ¼ βIntervention  X1 þ βTwelve months þ βInterventionTwelve months  X2
Example MANSA:
Estimated mean for the intervention group: Y3months = 2.36 ∗ 1 + 1.81 + (−2.80 ∗ 1) = 1.37.
Estimated mean for the control group: Y3months = 2.36 ∗ 0 + 1.81 = (−2.80 ∗ 0) = 1.81.
Estimated mean difference between intervention and control group: ΔY3 months = 1.37–1.81 =
The MANSA score for the intervention group is−0.44 lower compared to the control group af
Abbreviations: CDSS: Calgary Depression Scale for Schizophrenia; PANSS: Positive andNegative
Manchester Short Assessment of Quality of Life; CI: confidence interval; SE: standard error.
p-values significant at alpha b0.5 were indicated in bold.
a Reference category is control condition.
b Time was entered as dummy variables for the 3-month and 12-month measurement; bas
c Reference category is the difference from baseline to the 3-month measurement for the co
d Reference category is the difference from baseline to the 12-month measurement for the c
⁎ Results of linear mixed models analyses on CDSS, PANSS, HoNOS and MANSA scores adjusdistributed continuous variables. Differences on psychosocial outcomes
over time were analyzed according to the intention-to-treat principle
using a likelihood-based multi-level linear mixed model with an un-
structured covariance structure, taking the randomization strata of
teams into account. To investigate the effect for the two phases of the in-
tervention separately, we created two dummy variables for time, where
the reference category was baseline compared to the 3-month and 12-
month measurements respectively. Condition, dummy variables for
time and interaction terms of condition x time were entered into the
model asfixed factors. Age, gender, chlorpromazine equivalents and liv-
ing situation were entered as covariates. SPSS version 22was used with
alpha set at 0.05.
2.6. Post hoc analyses
Post-hoc analyses were performed to investigate whether baseline
differences could be explained by the uneven distribution of living situ-
ation over the groups, as living situationmight reflect the severity of ill-
ness and illness-related consequences (i.e. the degree of dependence on
others for daily tasks is likely higher in clinical care facilities). Analysis of
variance (ANOVA) was performed on baseline differences with condi-
tion as predictor and living situation as covariate. In addition, the effectal patients.⁎





















ol group over time, the following formula can be used, with X1 and X2 = 0 for the control
−0.44.
ter three months of intervention.
Syndrome Scale – remission items; HoNOS; Health of theNation Outcome Scales;MANSA:
eline is the reference category.
ntrol condition.
ontrol condition.
ted for age, gender, chlorpromazine equivalents and living situation.
411A.P.M. Stiekema et al. / Schizophrenia Research 199 (2018) 407–413of the intervention on psychosocial outcomes was investigated sepa-
rately for sheltered facilities and clinical care facilities using the linear
mixed models described above, to examine whether the intervention
may have a different effect on patients in sheltered facilities than on pa-
tients in clinical facilities. Finally, we investigatedwhether the improve-
ment on somatic outcome waist circumference (WC) after three
months of intervention (Looijmans et al., 2017), was related to im-
provements in mental well-being in patients in the intervention
group. Intervention patients were split by median on WC differences
scores from baseline till 3-months, leading to an ‘improvement/equal’
group (increase WC ≤ 0 cm) and a ‘deterioration’ group (increase WC
N1 cm). Linearmixedmodels analyseswere used to testwhether groups
differed in their psychosocial outcomes over time.
3. Results
3.1. Patient characteristics
Fifteen teams (nine sheltered and six clinical care teams, 400 pa-
tients) were allocated to the intervention group and 14 teams (nine
sheltered and five clinical care teams, 414 patients) to the control
group. Out of the 814 patients automatically included, 770 patients
(384 intervention and 386 control patients) had data on at least one
psychosocial measure at baseline or the 12-month measurement, mak-
ing them eligible for analysis (see Fig. 1). Despite randomization, pa-
tients in the intervention group were on average older, were
prescribed higher doses of antipsychotic medication and more patients
in the intervention group were diagnosed with a substance related dis-
order or living in clinical care facilities (see Table 1). The intervention
group reported less depressive symptoms and had a higher quality of
life at baseline. Living situation fully explained baseline differences be-
tween intervention and control group for antipsychotic dosage, partly
explained differences in age but could not explain the differenceFig. 2.Crudemean scores on psychosocial outcomes over time. Crudemean scores on the a) dep
range 7–56), c) overall functioning (HoNOS; range 0–48) and d) quality of life (MANSA; range 1
symptoms/functioning on CDSS, PANSS and HoNOS, but better quality of life on MANSA. Aste
marked time point compared to baseline.between the groups with regard to substance related disorder, depres-
sive symptoms and quality of life.3.2. Psychosocial outcomes
The intervention had no effect on the course of depressive symp-
toms, psychotic symptoms or overall functioning (Table 2, Fig. 2). The
course of quality of life (possible range 12–84) differed between groups;
the intervention group showed a significant reduction (−0.97 points
after three months and −1.66 points after twelve months), the control
group a significant increase (1.38 points after three months and 1.36
points after twelve months). Group difference were significant for
both periods (β=−2.80, p= .011 andβ=−4.18, p b .001, respective-
ly), but themain change took place in the first threemonths. In sensitiv-
ity analyses controlling for initial baseline differences, the effects
remained the same.3.3. Post hoc analyses
Outcomes were different for the sheltered and clinical facilities
(Supplementary Table 1, Supplementary Fig. 1). The clinical care inter-
vention group showed a significant increase in depressive symptoms
(possible range 0–27) after three (mean difference: 0.93 points) and
after twelve months (0.96 points), while the depressive symptoms of
the control group reduced (−0.40 and −0.16 points after three and
twelve months; β = 0.57, p = .003 and β = 0.39, p = .030). The shel-
tered intervention group showed a significantly greater increase in psy-
chotic symptoms (possible range 8–56) from baseline to the 12-month
measurement (2.61 points) than the control group (0.05 points; β =
1.79, p= .001). For quality of life, the intervention group showed a de-
crease over time (−1.07 points after three months and −3.03 points
after twelve months) compared to an increase of the control groupressive symptoms (CDSS; range 0–27), b) psychotic symptoms (remission items of PANSS;
2–84) for intervention and control group over time. Note that higher scores indicate worse
risks indicate significant differences between the intervention and control group of the
412 A.P.M. Stiekema et al. / Schizophrenia Research 199 (2018) 407–413(1.65 points after three months and 1.48 points after twelve months; β
= −2.84, p = .040 and β = −5.84, p b .001, respectively).
Intervention patients who improved or stabilized in waist circum-
ference after three months of intervention (N= 99; 53.5%) did not dif-
fer in quality of life, psychosocial functioning or depressive and
psychotic symptoms after three and twelve months of intervention
compared to deteriorating patients (N = 86; 46.5%; data not shown).
4. Discussion
This study examined the psychosocial effects of a 12-month diet-
and-exercise lifestyle intervention targeting the obesogenic environ-
ment of residential patients with SMI. The intervention did not lead to
improvements in psychosocial well-being compared to standard care.
Instead, the intervention group showed an increase of depressive symp-
toms (only in clinical care facilities) and a decreased quality of life (only
in sheltered facilities). Improvements in somatic health (waist circum-
ference) after three months of intervention (Looijmans et al., 2017),
were not associated with improvements in psychosocial well-being.
Interpreting the slight deterioration in mental well-being is compli-
cated since the intervention group had significantly less depressive
symptoms and better quality of life at baseline. Thus, changes over
time could be the result of regression toward the mean rather than an
effect of the intervention. Furthermore, these changes are small: one
point on the CDSS, of which theminimal clinically important difference
(MCID) is 1.3 points (Amri et al., 2014) and 1.5 point on the MANSA
which, although the MCID is unknown, seems small compared to the
possible range of 12–84 points. In addition, baseline levels of all psycho-
social outcomes were already remarkably good. This may be due to an
optimal medication balance that has been established over the years,
patients having come to terms with their current living situation, and
the high level of psychosocial support in residential settings
(Heggelund et al., 2011). Improvements are therefore harder to achieve,
especially by an intervention not specifically designed for improve-
ments in mental well-being. Thus, these findings may be a result of
non-optimal randomization and may not reflect clinically relevant
changes in well-being. The increase in psychotic symptoms in the shel-
tered intervention groups is hard to interpret, it is unclear whether this
is due to factors related or unrelated to the study.
Nevertheless, it is possible that a growing awareness of the risks of
having an unhealthy lifestyle, while possibly having insufficient oppor-
tunities to change lifestyle behaviors, unintentionally affected psycho-
social outcomes negatively. While not assessed, some experimental
teams indeed perceived barriers to implementation of the intervention
on organizational level (e.g. in changing the food that is prepared by a
central kitchen), on team level (e.g. staff members are hesitant to take
away unhealthy choices) and on patient level (e.g. some patients
could not be motivated or considered reducing health risks difficult).
Furthermore, changing the environment requires a change in the
existing culture in which lifestyle and somatic health have long been
neglected, which takes time (Cohn et al., 2010; Walsh, 2011). At some
sites the changes were implemented in the monitoring phase rather
than in the implementation phase and therefore had less time to be-
come effective. In addition, the small change approach may have led
to environmental changes that were too small to bring about detectable
changes in psychosocial functioning during the study period.
Another possible explanation for our findings is that the causal rela-
tionship between lifestyle factors and psychosocialwell-being isweaker
in the SMI population than in the general population. Several pathways
have been proposed for the general population. For example, exercise is
thought to have a positive effect through increased levels of endorphins
or serotonin, and through psychological changes such as increased self-
efficacy, self-esteem, and interruptions from negative thoughts (Ross
and Hayes, 1988; Stathopoulou et al., 2006). Dietary quality may have
an effect through biological processes such as the stress response sys-
tem (Sarris et al., 2014) or, when shifting to healthier diet, throughthe experience of successful behavior change (Carson et al., 2014). De-
spite positive effects of lifestyle interventions in the general population
(Rethorst et al., 2009), the evidence in SMI is limited or stems from
methodologically challenged studies (Ball et al., 2001; Beebe et al.,
2005; Brar et al., 2005; Forsberg et al., 2010; Heggelund et al., 2011;
Hoffmann et al., 2005; Kwon et al., 2006; Mauri et al., 2008; Melamed
et al., 2008; Poulin et al., 2007). The current findings could indicate
that the effects of changes in lifestyle on psychosocial functioning is
not as strong, or even absent, in SMI patients compared to the general
population. This should be elucidated in future research.
The ELIPS study has unique strengths beyond the large representa-
tive sample of a population that is rarely the subject of intervention
studies. The pragmatic nature of the trial has several advantages, such
as a high generalizability and high clinical value (Patsopoulos, 2011):
The study design allowed regular staff members to adopt changes in
real life settings that fitted well within the team's specific daily working
routine. However, the downside of pragmatic trials is limited control
over the specific interventions used, the degree of implementation in
the experimental teams and the degree to which health behaviors
were stimulated in the control group. Future pragmatic trials should in-
clude a process evaluation to investigate the reach, dose delivery and
adherence of the intervention, and whether sites with a higher level of
implementation are able to reach more health gain. Another limitation
is that no specific efforts were undertaken to improve psychosocial
functioning, as theprimarily aimwas to reduce cardiometabolic risk fac-
tors. Lifestyle interventions may need to be combined with individual
counselling or behavioral therapy to have a positive effect on psychoso-
cial functioning. However, studies primarily focusing on improving psy-
chosocial well-being in patients with long-term complex mental illness
have failed in doing so, suggesting that psychosocial outcomes are diffi-
cult to influence in thismore complex group of patients (Crawford et al.,
2010; Killaspy et al., 2015).
This is the first large multicentre randomized trial to investigate the
effect of a lifestyle intervention targeting the obesogenic environment
of residential SMI patients. The study showed no improvements in psy-
chosocial well-being after three or twelve months. More research, in-
cluding process evaluation, is needed to investigate the effect of
different types of lifestyle interventions on somatic as well as psychoso-
cial outcomes, including an examination of barriers to success and how
to overcome them.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.schres.2018.02.053.
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